NR 602- Kawasaki Disease Presentation

NR 602- Kawasaki Disease Presentation

NR 602- Kawasaki Disease Presentation

Kawasaki disease (KD) is an intriguing acute, self-limiting vasculitis with unknown etiology. It usually affects young population ages 2-5 years old and it is known as the most common cause of acquired heart disease in children worldwide (McCrindle et al., 2017). Statistically, the disease is reportedly common in Asian populations particularly in Japan and Korea, so it is said to be linked with genetic predisposition. Although the etiology of KD is unknown, ….

In 2017, AHA published the online clinical guidelines of diagnosis, treatment, and long-term management of Kawasaki disease. Diagnosis is based on …

The main goal to prevent complications of Kawasaki disease. Unfortunately, there is no specific prevention and diagnostic testing for this disease. However, if early diagnosis and treatment regimen is provided …

Answers to my Lead Questions:

• What causes Kawasaki disease in children’s?

No one knows what causes Kawasaki Disease in kids. However, the hypothesis reported by researchers, it may be cause by an immune disorder in which an infectious agent such as bacteria or virus causes overreaction of the immune system leading to inflammations of organs, heart, and tissues in the body.  Researchers also leads to think that KD is developed due to genetically susceptible child.

• How does Kawasaki disease affects the heart?

KD causes inflammation of heart muscles, valves and blood vessels that supply the coronary arteries. Dilation of the coronary arterial wall results in aneurysms of the arteries and thrombosis can occur. Blood clot and aneurysm blocks the blood flow in the heart which can result in a heart attack.

ORDER NOW FOR AN ORIGINAL, PLAGIARISM-FREE, AND RESOURCEFUL PAPER

• List at least 3 heart complications of Kawasaki Disease?

Kawasaki disease is said to be a leading cause of acquired heart disease in children if not treatment in a timely manner (McCrindle et al., 2017). With effective immediate treatment, only small % of cardiac damage was reported. However, some of the possible heart complications can include inflammation of blood vessels (vasculitis), myocarditis, mitral regurgitations, dysrhythmia, and the most fatal is myocardial infarction.

This week has been very busy, productive, and informative. I did struggle managing my time with the project (Kaltura particularly), practicum hours, working in the hospital, readings, qbanks, and discussion post. Overall, I enjoyed my presentation and I am learning a lot with my preceptor and on my pediatrics encounters in my clinical site.

ORDER NOW FOR AN ORIGINAL, PLAGIARISM-FREE, AND RESOURCEFUL PAPER

NR 602- Kawasaki Disease Presentation References

McCrindle, B. W., Rowley, A. H., Newburger, J. W., Burns, J. C., Bolger, A. F., Gewitz, M., … & Kobayashi, T. (2017). Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association. Circulation, 135(17), e927-e999.

Miura, M. (2018). Role of glucocorticoids in Kawasaki disease. International journal of rheumatic diseases, 21(1), 70-75.

Newburger, J. W., Takahashi, M., & Burns, J. C. (2016). Kawasaki disease. Journal of the American College of Cardiology, 67(14), 1738-1749.

NB. This is an incomplete Sample Response.